Literature DB >> 2768832

Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.

J L Held1, S Sassa, A Kappas, L C Harber.   

Abstract

We measured uroporphyrinogen decarboxylase (UROD) activity in erythrocyte lysates obtained from 40 consecutive patients with porphyria cutanea tarda (PCT) without selection for family history. Enzyme determinations indicated that 28% of the patients had abnormally decreased UROD activity in erythrocytes; this finding did not always correlate with family history. Two siblings with PCT and normal erythrocytic, but abnormally decreased hepatic UROD activities, were encountered. This finding suggests that familial PCT may occur not only with decreased erythrocyte UROD activity, but also with a normal UROD activity in erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768832

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

Review 1.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

Review 2.  Uroporphyrinogen decarboxylase.

Authors:  G H Elder; A G Roberts
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

3.  Angiosarcoma, porphyria cutanea tarda, and probable chloracne in a worker exposed to waste oil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  R McConnell; K Anderson; W Russell; K E Anderson; R Clapp; E K Silbergeld; P J Landrigan
Journal:  Br J Ind Med       Date:  1993-08

4.  Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population.

Authors:  L D'Alessandro; D Griso; G Biolcati; A Macrì; G C Topi
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase.

Authors:  John D Phillips; Frank G Whitby; James P Kushner; Christopher P Hill
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.